Education
About Us
Working with TipRanks
Follow Us
Jacobson Pharma Corporation Limited (HK:2633)
:2633
RESEARCH TOOLSreports
2633 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$1.78
Previous CloseN/A
Volume1.98M
Average Volume (3M)866.42K
Market Cap
HK$2.81B
Enterprise ValueHK$2.63B
Total Cash (Recent Filing)HK$563.79M
Total Debt (Recent Filing)HK$699.85M
Price to Earnings (P/E)9.8
Beta0.20
Next Earnings
Nov 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 11, 2025Dividend Yield4.03%
Share Statistics
EPS (TTM)0.08
Shares Outstanding2,000,221,000
10 Day Avg. Volume1,058,218
30 Day Avg. Volume866,424
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$1.50Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering0
Jacobson Pharma Corporation Limited News
2633 FAQ
What was Jacobson Pharma Corporation Limited’s price range in the past 12 months?
Jacobson Pharma Corporation Limited lowest stock price was HK$0.56 and its highest was HK$1.78 in the past 12 months.
What is Jacobson Pharma Corporation Limited’s market cap?
Jacobson Pharma Corporation Limited’s market cap is HK$2.81B.
When is Jacobson Pharma Corporation Limited’s upcoming earnings report date?
Jacobson Pharma Corporation Limited’s upcoming earnings report date is Nov 21, 2025 which is in 91 days.
How were Jacobson Pharma Corporation Limited’s earnings last quarter?
Jacobson Pharma Corporation Limited released its earnings results on Jun 13, 2025. The company reported HK$0.081 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.081.
Is Jacobson Pharma Corporation Limited overvalued?
According to Wall Street analysts Jacobson Pharma Corporation Limited’s price is currently same.
Does Jacobson Pharma Corporation Limited pay dividends?
Jacobson Pharma Corporation Limited pays a Notavailable dividend of HK$0.055 which represents an annual dividend yield of 4.03%. See more information on Jacobson Pharma Corporation Limited dividends here
What is Jacobson Pharma Corporation Limited’s EPS estimate?
Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jacobson Pharma Corporation Limited have?
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.
What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?
Jacobson Pharma Corporation Limited reported an EPS of HK$0.081 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.937%.
Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?
Currently, no hedge funds are holding shares in HK:2633
Jacobson Pharma Corporation Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$1.50 (0.00% )
HK$1.50 (0.00% )
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
206.12%
12-Months-Change
Fundamentals
Return on Equity
12.47%
Trailing 12-Months
Asset Growth
4.54%
Trailing 12-Months
Company Description
Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
Technical Analysis
Lee's Pharmaceutical Holdings Limited
―
JBM (Healthcare) Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
China Shineway Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Ownership Overview
―
Insiders
0.04%
Mutual Funds
― Other Institutional Investors
99.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---